@EMBL
Homepage: https://www.embl.org/groups/zimmermann/
Luka is coming from Montenegro and will work on high-throughput exploration of the metagenomic sequence space.
Welcome🎉🎊
Luka is coming from Montenegro and will work on high-throughput exploration of the metagenomic sequence space.
Welcome🎉🎊
Welcome to the team! 🎉
Welcome to the team! 🎉
We profiled thousands of microbe–drug interactions across gut species as a first step toward understanding — and eventually predicting — how the microbiome shapes drug metabolism.
We profiled thousands of microbe–drug interactions across gut species as a first step toward understanding — and eventually predicting — how the microbiome shapes drug metabolism.
Check out the EMBL ARISE2 Fellowship Programme!
🔗 www.embl.org/training/ari...
📩 Contact: Juan Antonio Vizcaíno — Team Leader, EMBL-EBI
🔗 www.ebi.ac.uk/people/perso...
📌 Applications close soon!
📆 30/09/2025
More info below👇
Check out the EMBL ARISE2 Fellowship Programme!
🔗 www.embl.org/training/ari...
📩 Contact: Juan Antonio Vizcaíno — Team Leader, EMBL-EBI
🔗 www.ebi.ac.uk/people/perso...
📌 Applications close soon!
📆 30/09/2025
More info below👇
#Metabolomics #Microbiome
#Metabolomics #Microbiome
His findings aim to provide insights into CRC development and aid in developing therapeutics against pathogenic biofilms.
His findings aim to provide insights into CRC development and aid in developing therapeutics against pathogenic biofilms.
Leyla is our new master's student and she will combine public untargeted metabolomics data & machine learning to predict potential drug biotransformation in gut microbes by highlighting key metabolic interactions.
Leyla is our new master's student and she will combine public untargeted metabolomics data & machine learning to predict potential drug biotransformation in gut microbes by highlighting key metabolic interactions.